Gypsophila eriocalyx
Gypsophila eriocalyx · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Gypsophila eriocalyx is a medicinal plant recognized for its potent therapeutic potential and diverse biological activities. Recent research focuses on the antioxidant properties of Gypsophila eriocalyx extract (GEE) to combat various pathological conditions. Specifically, this plant extract has shown promise in addressing complex issues such as Alzheimer's Disease and regulating apoptosis. Furthermore, its efficacy is being tested against harmful pathogens like Bacillus cereus to determine its broader antimicrobial scope. To enhance delivery and stability, advanced preparations such as GEE-loaded chitosan nanoparticles (CNPs) are currently being utilized in scientific studies.
- Synonyms
- Acanthophyllum Mite · Gypsophila Henrici · 1 more
- Common names
- Not available
- Family
- Caryophyllaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Gypsophila eriocalyx is a unique botanical species that is recognized by various names depending on the local language and region. In Turkey, this plant is commonly referred to by its local name, Bozkır çöveni. Meanwhile, in different linguistic contexts, it is known as Качим пушисточашечный. These diverse common names reflect the plant's widespread presence and cultural identity across various territories. Understanding these regional designations helps botanists and enthusiasts identify the species more easily throughout its natural habitat.
Sources: Catalogue of Life (COL)
Synonyms
Gypsophila eriocalyx is a botanical species known to be associated with several different taxonomic synonyms. Within scientific literature, it has been identified under the alternative name Acanthophyllum mite. The plant is also linked to the specific variety known as Gypsophila eriocalyx var. henrici. Furthermore, the nomenclature includes the synonym Gypsophila henrici to describe its various classifications. Understanding these overlapping relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Gypsophila eriocalyx is a distinctive botanical specimen that belongs to the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. This plant is a member of the order Caryophyllales, which defines many of its structural characteristics. It further resides within the family Caryophyllaceae, a group known for its diverse floral arrangements. Ultimately, this species is categorized under the specific genus Gypsophila.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Caryophyllales |
| Family | Caryophyllaceae |
| Genus | Gypsophila |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Gypsophila eriocalyx is a specialized plant species primarily distributed throughout the Asia-Temperate region. Its natural habitat is most prominently concentrated within the landscapes of Western Asia. Within this broad geographical range, Türkiye serves as a key area where the species can be found thriving. Understanding these specific locational patterns provides vital insight into the environmental requirements of the plant. Consequently, studying its presence in these particular territories helps botanists map its ecological footprint more accurately.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Gypsophila eriocalyx is a compact species that typically maintains a modest stature in the landscape. Its growth generally ranges from a minimum height of 0.2 m to a maximum of 0.4 m.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Gypsophila eriocalyx is an endemic medicinal plant from northern central Turkey that possesses significant pharmacological potential. Research indicates that different extracts of this plant exhibit notable antioxidant activity, with methanol and ethanol versions performing more effectively than water-based extracts. These antioxidant properties suggest that the plant could serve as a functional therapy for managing diseases driven by oxidative damage. Beyond its antioxidant capacity, the plant also demonstrates antimicrobial effects and the ability to inhibit the viability of certain breast cancer cells. Ultimately, the multifaceted biological profile of Gypsophila eriocalyx makes it a promising candidate for treating progressive conditions like cancer and diabetes.
Compounds
Conditions
Gypsophila eriocalyx demonstrates significant therapeutic potential by acting as a functional therapy for the management of Alzheimer's disease. The plant's extracts exhibit potent antimicrobial properties, specifically showing effectiveness against Bacillus cereus and Staphylococcus aureus. In oncological studies, the plant has been shown to treat MDA-MB-231 breast cancer cells by inhibiting their viability in a dose-dependent manner. This anti-cancer activity is further supported by the plant's ability to induce S phase cell-cycle arrest and apoptosis. Together, these biological activities highlight the plant's diverse medicinal capabilities against various infections and progressive diseases.
Preparations
Gypsophila eriocalyx is prepared as a plant extract to investigate its various biological and pharmacological properties. Within this plant extract, specific formulations such as Gypsophila eriocalyx extract (GEE) are produced to determine their chemical components and molecular interactions. This GEE is further processed and prepared as GEE-loaded chitosan nanoparticles (CNPs) to serve as a controlled drug carrier system. These specialized nanoparticles are evaluated for their ability to promote osteogenic proliferation in human bone marrow stem cells. Ultimately, the preparation of these different forms of Gypsophila eriocalyx aims to develop effective phytotherapeutic candidates for treating conditions like osteoporosis and cancer.